GAPDH and multiple sclerosis: In fact, recent data suggests that the beneficial effects of DMF in multiple sclerosis comes from DMF targeting, succinating and inactivating the catalytic cysteine within the active site of GAPDH.24 This provides a proof-of-concept in patients that GAPDH might be an intriguing target for an anti-inflammatory effect.